The ultimate goal of BIO is to see more inventions save and improve lives while serving as a basis of new companies that spread prosperity.
Of the 27 antiretroviral drugs now approved for AIDS, seven were tested first in patients at the 1917 Clinic in Phase 1 clinical trials.
The findings are the first to show that structural remodeling of the brain occurs during rehabilitation in a pediatric population.
Patients with rheumatoid arthritis have an increased risk for shingles, but new research at UAB indicates that biologics – the newest RA medications – don’t worsen that risk.
New study in European Heart Journal contradicts a recent study in the same publication, suggests evidence is lacking that digoxin increases mortality as atrial fibrillation treatment.
In an engineering feat, the UAB Comprehensive Cancer Center installs a cyclotron unique to academic medical settings.
New marker predicts how resistant each patient’s brain cancer will be to chemotherapy.
Strengths cited for UAB are the quality of training and mentoring and career development opportunities and networking.
Study authors say manipulating hormonal signals could effectively counter age-related cognitive decline.
Prematurity, low birth weight leading cause for the leveling off of infant mortality and neonatal mortality rates in the United States.